In epithelioid PM, OS gains were modest and did not reach statistical significance, although the high ORR with pembrolizumab‐based regimens suggests early cytoreductive activity and symptomatic improvement [ 92 ].
← all excerpts
Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview.
1
—
—